×
About 1,989 results

ALLMedicine™ Infantile Hemangioma Center

Research & Reviews  949 results

Melanocytes determine angiogenesis gene expression across human tissues.
https://doi.org/10.1371/journal.pone.0251121
PloS One; Freilikhman S, Halasi M et. al.

May 13th, 2021 - Several angiogenesis-dependent diseases, including age-related macular degeneration and infantile hemangioma, display differential prevalence among Black, as compared to White individuals. Although socioeconomic status and genetic architecture hav...

Evaluation of plasma and urinary levels of vascular endothelial growth factor and matri...
https://doi.org/10.1111/ijd.15640
International Journal of Dermatology; Rotter A, Lima XT et. al.

May 7th, 2021 - The pathogenesis of infantile hemangioma (IH) is not fully understood. It has been suggested that angiogenic factors increase in the proliferative stage, decreasing subsequently in the regression phase. To evaluate vascular endothelial growth fact...

Overexpression Prox1 in HemECs resembles Kaposiform hemangioendothelioma and cytotoxici...
https://doi.org/10.1016/j.jpedsurg.2021.03.023
Journal of Pediatric Surgery; Wang J, Han Q et. al.

Apr 18th, 2021 - Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor that occurs in children. Prox1 is a specific lymphatic marker for KHE. We intended to establish a Prox1 transgenic cell line resembling KHE and investigate the mechanism of sirolimus i...

Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027942
JAMA Dermatology; Muñoz-Garza FZ, Ríos M et. al.

Apr 7th, 2021 - Treatment of infantile hemangioma (IH) with topical timolol in the first 2 months of life (early proliferative phase) may prevent further growth and the need for treatment with oral propranolol. To our knowledge, no studies have determined whether...

see more →

Guidelines  3 results

The Use of ?-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by th...
https://www.aaojournal.org/article/S0161-6420(18)31999-7/fulltext
Hutchinson, A.,et al

Jul 31st, 2018 - There is limited evidence to support the safety and efficacy of both topical and systemic ?-blockers to promote regression of periocular hemangiomas. Additional research may confirm the best dosage and route of administration to maximize efficacy.

Diagnosis and Management of Infantile Hemangioma: Executive Summary.
https://doi.org/10.1542/peds.2015-2482
Pediatrics Darrow DH, Greene AK et. al.

Sep 29th, 2015 - Diagnosis and Management of Infantile Hemangioma: Executive Summary.|2015|Darrow DH,Greene AK,Mancini AJ,Nopper AJ, ,|diagnosis,therapy,diagnosis,therapy,

Diagnosis and Management of Infantile Hemangioma.
https://doi.org/10.1542/peds.2015-2485
Pediatrics Darrow DH, Greene AK et. al.

Sep 29th, 2015 - Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors, they have the unique ability to involute after proliferation, often leading primary care providers to assume they will resolve without intervention or conseq...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  979 results

Melanocytes determine angiogenesis gene expression across human tissues.
https://doi.org/10.1371/journal.pone.0251121
PloS One; Freilikhman S, Halasi M et. al.

May 13th, 2021 - Several angiogenesis-dependent diseases, including age-related macular degeneration and infantile hemangioma, display differential prevalence among Black, as compared to White individuals. Although socioeconomic status and genetic architecture hav...

Evaluation of plasma and urinary levels of vascular endothelial growth factor and matri...
https://doi.org/10.1111/ijd.15640
International Journal of Dermatology; Rotter A, Lima XT et. al.

May 7th, 2021 - The pathogenesis of infantile hemangioma (IH) is not fully understood. It has been suggested that angiogenic factors increase in the proliferative stage, decreasing subsequently in the regression phase. To evaluate vascular endothelial growth fact...

Overexpression Prox1 in HemECs resembles Kaposiform hemangioendothelioma and cytotoxici...
https://doi.org/10.1016/j.jpedsurg.2021.03.023
Journal of Pediatric Surgery; Wang J, Han Q et. al.

Apr 18th, 2021 - Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor that occurs in children. Prox1 is a specific lymphatic marker for KHE. We intended to establish a Prox1 transgenic cell line resembling KHE and investigate the mechanism of sirolimus i...

Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027942
JAMA Dermatology; Muñoz-Garza FZ, Ríos M et. al.

Apr 7th, 2021 - Treatment of infantile hemangioma (IH) with topical timolol in the first 2 months of life (early proliferative phase) may prevent further growth and the need for treatment with oral propranolol. To our knowledge, no studies have determined whether...

see more →

News  53 results

Timolol shortens propranolol use in infantile hemangioma
https://www.mdedge.com/dermatology/article/202247/dermatology/timolol-shortens-propranolol-use-infantile-hemangioma?channel=276
Christopher Palmer

Jun 4th, 2019 - Sequential therapy of oral propranolol then topical timolol for infantile hemangioma helped shorten duration of propranolol and maintain treatment success, according to a study published in Pediatric Dermatology. hypotekyfidler/Getty Images Diana.

Management of Infantile Hemangiomas Clinical Practice Guidelines (2019)
https://reference.medscape.com/viewarticle/908544

Feb 5th, 2019 - The guidelines on the management of infantile hemangioma were released on December 24, 2018, by the AAP.[1,2] Five indications for early treatment of problematic infantile hemangiomas (IHs) include the following: Life-threatening lesions, such as ...

AAP infantile hemangioma guideline should empower primary care clinicians
https://www.mdedge.com/clinicianreviews/article/192799/dermatology/aap-infantile-hemangioma-guideline-should-empower
Jill D. Pivovarov

Jan 16th, 2019 - The American Academy of Pediatrics has issued its first clinical practice guideline on infantile hemangiomas (IHs), given the dramatic increase in information available over the past decade. The aim in providing an evidence-based approach to evalu.

AAP Guideline Urges Prompt Care for Infantile Hemangiomas
https://www.staging.medscape.com/viewarticle/906955

Dec 23rd, 2018 - In a new clinical practice guideline on the management of infantile hemangioma (IH), the American Academy of Pediatrics (AAP) recommends that infants at high risk for complications receive a referral to a specialist for evaluation and possible tre...

AAP Guideline Urges Prompt Care for Infantile Hemangiomas
https://www.medscape.com/viewarticle/906955

Dec 23rd, 2018 - In a new clinical practice guideline on the management of infantile hemangioma (IH), the American Academy of Pediatrics (AAP) recommends that infants at high risk for complications receive a referral to a specialist for evaluation and possible tre...

see more →

Patient Education  3 results see all →